Found: 6
Select item for more details and to access through your institution.
Inhibition of acyl-CoA binding protein (ACBP) by means of a GABA<sub>A</sub>Rγ2-derived peptide.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 4, p. 1, doi. 10.1038/s41419-024-06633-6
- By:
- Publication type:
- Article
Correction: An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA receptor.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA<sub>A</sub> receptor.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 4, p. 1, doi. 10.1038/s41419-022-04834-5
- By:
- Publication type:
- Article
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 6, p. 1, doi. 10.1038/s41419-021-03864-9
- By:
- Publication type:
- Article
Acyl-CoA binding protein for the experimental treatment of anorexia.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 760, p. 1, doi. 10.1126/scitranslmed.adl0715
- By:
- Publication type:
- Article
High plasma concentrations of acyl‐coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP.
- Published in:
- Aging Cell, 2023, v. 22, n. 1, p. 1, doi. 10.1111/acel.13751
- By:
- Publication type:
- Article